Trends and Regional Differences in the Prescription of Prostaglandin Analogs for Glaucoma in England from 2019 to 2024 - Scorecard - MDSpire

Trends and Regional Differences in the Prescription of Prostaglandin Analogs for Glaucoma in England from 2019 to 2024

  • By

  • David Grant Robinson

  • Angela Whitaker

  • April 22, 2026

  • 0 min

Share

Clinical Scorecard: Trends and Regional Differences in the Prescription of Prostaglandin Analogs for Glaucoma in England from 2019 to 2024

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with glaucoma and ocular hypertension, particularly those over 50 years old, including specific mention of ocular hypertension.
Care Setting

Key Highlights

  • additional_highlight

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • R
      • e
      • g
      • u
      • l
      • a
      • r
      • a
      • s
      • s
      • e
      • s
      • s
      • m
      • e
      • n
      • t
      • o
      • f
      • i
      • n
      • t
      • r
      • a
      • o
      • c
      • u
      • l
      • a
      • r
      • p
      • r
      • e
      • s
      • s
      • u
      • r
      • e
      • a
      • n
      • d
      • p
      • a
      • t
      • i
      • e
      • n
      • t
      • r
      • e
      • s
      • p
      • o
      • n
      • s
      • e
      • t
      • o
      • t
      • r
      • e
      • a
      • t
      • m
      • e
      • n
      • t
      • ,
      • i
      • n
      • c
      • l
      • u
      • d
      • i
      • n
      • g
      • s
      • p
      • e
      • c
      • i
      • f
      • i
      • c
      • m
      • e
      • t
      • r
      • i
      • c
      • s
      • .

      Risks

        Patient & Prescribing Data

        Patients with glaucoma or ocular hypertension in England.

        Cost-effective prescribing of PGAs is essential due to high treatment costs.

        Clinical Best Practices

        • additional_practice

        References

        Original Source(s)

        Trends and Regional Differences in the Prescription of Prostaglandin Analogs for Glaucoma in England from 2019 to 2024

        • by David Grant Robinson, Angela Whitaker

        • April 22, 2026

        Related Content

        Inside Focus A-Eye’s Inaugural Meeting

        Sharon Bakalash, MD, PhD, CBA, describes how the interdisciplinary pre-ARVO forum explored ways to move AI from concept to clinic.

        Research priorities for diagnostics, progression monitoring, and treatment of glaucoma in myopic eyes

        The Art of Ophthalmology 2026

        Showcasing artwork and images from across the spectrum of ophthalmology